Health plans would reimburse enrolled pharmacists for certain covered services, while Medi-Cal payments for advanced practitioners and specialty drug support would depend on federal approval and available funding.
Plans and disability insurers would pay or reimburse enrolled pharmacists for covered services, including pharmacists at community health centers and rural clinics, when they cover similar care by other providers.
Medi-Cal would pay advanced pharmacist practitioners at least 85% of the physician-service rate, including for medication therapy management, if federal approval and funding are available.
With federal approval and funding, and a state appropriation, eligible clinic pharmacists and pharmacies could receive Medi-Cal payments for medication support tied to certain specialty drugs.
Health care plans and disability insurers would pay or reimburse enrolled pharmacists for covered services. This applies to health care service plans and disability insurers that offer coverage for services within a licensed pharmacist’s scope. Pharmacists working at federally qualified health centers and rural health clinics are included. Medi-Cal managed care plans are excluded from the health plan rule. The service must be within the pharmacist’s lawful scope and the coverage must pay for similar services by other licensed providers. Out-of-network pharmacy services qualify only if the plan or insurer offers that benefit. A provider cannot be paid twice for the same service.
Medi-Cal would pay advanced pharmacist practitioners at least 85% of the physician-service fee schedule. The minimum rate applies to advanced pharmacist practitioner services under Medi-Cal, including medication therapy management services. The Medi-Cal changes cannot be implemented until necessary federal approvals are obtained and may be implemented only where federal funding is available.
The state would recognize advanced pharmacist practitioners at federally qualified health centers and rural clinics for Medi-Cal payment and set up a payment method for eligible specialty drug support. The payment method covers medication therapy management linked to specialty drug categories selected by the state. Eligible providers include contracted Medi-Cal pharmacies and advanced pharmacist practitioners. The state must obtain federal approval, and federal funding must be available. Clinic recognition also depends on a state budget appropriation. The payment method is subject to an annual appropriation. Only eligible advanced pharmacist practitioners or pharmacies with a state contract may receive these payments. The payment method would apply to services on or after July 1, 2021, or the effective date of necessary federal approval, whichever is later.
No hearings or votes scheduled.